COMMUNIQUÉS West-GlobeNewswire

David Kendall Joins MannKind as Chief Medical Officer
06/02/2018
WESTLAKE VILLAGE, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD ) today announced that David M. Kendall, MD, will join the company as Chief Medical Officer and assume full responsibility [...]
Easton Pharmaceuticals Announces Negotiations for a New Sub-Distribution Agreement for One of Its Woman’s Diagnostic / Treatment Products & Provides Update on Its Alliance Operations
06/02/2018
TORONTO, ON, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals, Inc. (OTC: EAPH), announces it has initiated discussions to transfer part of its licensed woman’s diagnostic and treatment products to another [...]
Zogenix Announces Receipt of FDA Breakthrough Therapy Designation for ZX008 in Dravet Syndrome
06/02/2018
EMERYVILLE, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]
Immunomedics to Report Second Quarter Fiscal 2018 Results and Host Conference Call and Webcast on February 8, 2018
06/02/2018
MORRIS PLAINS, N.J., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that it will host a conference call on Thursday, February 8, 2018 at 5:00 p.m. [...]
Actinium Pharmaceuticals Announces Trial to Study Actimab-A in Combination with CLAG-M for Relapsed or Refractory AML Patients
06/02/2018
- Actimab-A plus CLAG-M further expands Actinium’s CD33 program and addressable patient population of Actimab-A - Combination aligns with Actinium’s focus on improving bone marrow transplant access and outcomes through [...]
Otonomy Announces Multiple Presentations for Hearing Loss and Tinnitus Programs at Upcoming Association for Research in Otolaryngology Meeting
06/02/2018
SAN DIEGO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC ), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced seven data presentations [...]
BioDelivery Sciences Announces BELBUCA® Patent Litigation Settlement Agreement with Teva
06/02/2018
RALEIGH, N.C., Feb. 06, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. and Teva [...]
Leap Therapeutics to Present at the 20th Annual BIO CEO & Investor Conference
06/02/2018
CAMBRIDGE, Mass., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, Chief [...]
ProQR to Present at Upcoming Scientific Meeting and Investor Conference
06/02/2018
LEIDEN, the Netherlands, Feb. 06, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR ), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe [...]
Cyclacel Pharmaceuticals to Present at the 2018 BIO CEO & Investor Conference
06/02/2018
BERKELEY HEIGHTS, N.J., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) (Cyclacel or the Company), a clinical-stage biopharmaceutical company using cell cycle, [...]
IRADIMED CORPORATION Announces Fourth Quarter 2017 Financial Results
06/02/2018
Reports fourth quarter 2017 revenue of $6.7 million Reports fourth quarter 2017 GAAP diluted EPS of $0.02 and non-GAAP diluted EPS of $0.10 Records one-time non-cash charge of $0.5 million related to tax reform WINTER [...]
Akari Therapeutics Announces Completion of Phase II COBALT Trial of Coversin in Patients with PNH and Further Progress of Clinical Trials
06/02/2018
The final three Paroxysmal Nocturnal Hemoglobinuria (PNH) patients enrolled into the Phase II COBALT trial with the revised dosing regimen had median LDH of < 1.5 times the ULN at Day 28, 60 and 90 Phase III clinical [...]
Wright Medical Group N.V. to Host Fourth Quarter 2017 Earnings Conference Call
06/02/2018
AMSTERDAM, The Netherlands, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI ) today announced that it will host a conference call on Tuesday, February 27, 2018, at 3:30 p.m. Central Time to [...]
ContraVir Pharmaceuticals Completes Renal Impairment Study with TXL™
06/02/2018
EDISON, N.J., Feb. 06, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]
Transactions in relation to share buyback program
06/02/2018
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
FIT Biotech Oy: RESOLUTIONS OF EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY FEBRUARY 6, 2018
06/02/2018
Company release February 6, 2018 at 12:15 EET RESOLUTIONS OF EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY FEBRUARY 6, 2018 The EGM of FIT Biotech Oy ("FIT Biotech", "Company") has made the following resolutions today [...]
Change of Chief Executive Officer
06/02/2018
MELBOURNE, Australia, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“Company”, “GTG”), advises that the Board and Mr Eutillio Buccilli have today agreed that Mr Buccilli step [...]
Thinking About a Facelift? Announcing a Skincare Range Specifically Created for Mature Women: The Azul SkinHealth Anti-Aging System
06/02/2018
NAPLES, Fla., Feb. 06, 2018 (GLOBE NEWSWIRE) -- As any one of the thousands of “snow birds” who flock to Florida for the winter will tell you, the Sunshine State, with its enviable climate, does have a downside – skin [...]
Xbrane Biopharma signs license agreement with CR Pharma for Spherotide in China
06/02/2018
Press release 2018-02-06 Xbrane Biopharma (publ.) ("Xbrane") and China Resource Pharmaceutical Group Limited ("CR Pharma") have entered into a license agreement which gives CR Pharma exclusive rights to market and sell [...]

Pages